Orexigen Therapeutics Inc (OREXQ)

OTC Markets
0.005
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.003 - 0.005

OREXQ Overview

Prev. Close
0.004
Day's Range
0.003-0.005
Revenue
-
Open
0.003
52 wk Range
0-0
EPS
-9.7
Volume
0
Market Cap
100.1K
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
469,115
P/E Ratio
-
Beta
5.19
1-Year Change
0%
Shares Outstanding
18,887,033
Next Earnings Date
-
What is your sentiment on Orexigen Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Orexigen Therapeutics Inc News

Orexigen Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellStrong Sell
Technical IndicatorsBuyBuyBuySellStrong Sell
SummaryBuyBuyBuySellStrong Sell

Orexigen Therapeutics Inc Company Profile

Orexigen Therapeutics Inc Company Profile

Employees
132

On May 31, 2019, Orexigen Therapeutics, Inc., went out of business as per its Chapter 11 liquidation filing under bankruptcy. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.

Read More
  • Hmm? What's the future outlook? Worth the investment?
    0
    • I think they are getting bankrupt
      0
  • WHATT HAPPEN ????
    0
    • Any ideas
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.